UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D. C. 20549 FORM 10-Q (X) Quarterly report pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934. For the quarterly period ended September 30, 2004 ( ) Transition report pursuant to Section 13 or 15(d) of the Exchange Act for the transition period from __________ to _____________ . Commission File Number: 333-100099 HydroFlo, Inc. (Exact name of registrant as specified in charter) North Carolina 56-2171767 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) 3721 Junction Blvd. Raleigh, NC 27603 (Address of principal executive offices) (919) 772-9925 (Registrant's Telephone Number, Including Area Code) Check whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES (X) NO ( ) State the number of shares outstanding of each of the issuer's classes of common equity, as of November 12, 2004. 31,611,441 Transitional Small Business Disclosure Format: YES ( ) NO (X) 1 HydroFlo, Inc. INDEX TO FORM 10-Q PART I. FINANCIAL INFORMATION Item 1. Financial Statements (unaudited) Balance Sheet as of September 30, 2004 and June 30, 2004........................................................... 4 Statements of Operations for the three months ended September 30, 2004 and 2003.............................................. 5 Statements of Cash Flows for the three months ended September 30, 2004 and 2003 ............................................. 6 Notes to Financial Statements.................................. 7 Management's Discussion and Analysis of Financial Condition Item 2. and Results of Operations (including cautionary statement)..... 11 Item 3. Quantitative and Qualitative Disclosure About Market Risk...... 13 Item 4. Controls and Procedures........................................ 13 PART II. OTHER INFORMATION Item 1. Legal Proceedings.............................................. 15 Item 2. Changes in Securities.......................................... 15 Item 3. Defaults Upon Senior Securities................................ 15 Item 4. Submission of Matters to a Vote of Securities Holders.......... 15 Item 5. Other Information.............................................. 15 Item 6. Exhibits and Reports on Form 8-K............................... 15 Signatures 15 2 PART I In this Quarterly Report, the "Company", "we", "us" and "our" refer to HydroFlo, Inc. and our wholly owned subsidiary unless the context otherwise requires. Different accounting principles are used in the preparation of financial statements of a business development company under the Investment Company Act of 1940 and, as a result, the financial results for periods ending before March 4, 2004 are not comparable to the periods commencing after March 4, 2004 and are not expected to be representative of our financial results in the future. FORWARD-LOOKING STATEMENTS This Form 10-Q, press releases and certain information provided periodically in writing or orally by our officers or our agents contain statements which constitute forward-looking statements within the meaning of Section 27A of the Securities Act, as amended; Section 21E of the Securities Exchange Act of 1934; and the Private Securities Litigation Reform Act of 1995. The words "may", "would", "could", "will", "expect", "estimate", "anticipate", "believe", "intend", "plan", "goal", and similar expressions and variations thereof are intended to specifically identify forward-looking statements. These statements appear in a number of places in this Form 10-Q and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of us, our directors or our officers, with respect to, among other things: (i) our liquidity and capital resources; (ii) our financing opportunities and plans; (iii) trends affecting our future financial condition or results of operations; (iv) our growth strategy and operating strategy; and (v) the declaration and payment of dividends. Investors and prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. The factors that might cause such differences include, among others, the following: (i) we have incurred significant losses since our inception, and have experienced and continue to experience negative operating margins and negative cash flows from operations (see Note A to the financial statements); (ii) any material inability of us to successfully internally develop our products; (iii) any adverse effect or limitations caused by Governmental regulations; (iv) any adverse effect on our cash flow or on our ability to obtain acceptable financing in connection with our growth plans; (v) any increased competition in our business; (vi) any inability of us to successfully conduct our business in new markets; and (vii) other risks including those identified in our filings with the Securities and Exchange Commission. We undertake no obligation to publicly update or revise the forward looking statements made in this Form 10-Q to reflect events or circumstances after the date of this Form 10-Q or to reflect the occurrence of unanticipated events. 3 HydroFlo, Inc. BALANCE SHEETS ____________________________________________________________________________________ September 30, 2004 June 30, (Unaudited) 2004 ASSETS INVESTMENTS IN AND ADVANCES TO CONTROLLED COMPANIES (at fair value with a cost of $2,631,578 and $2,008,000, respectively) $ 2,620,000 $ 2,011,000 CASH 359,632 406,762 PROPERTY AND EQUIPMENT (net of accumulated depreciation of $15,376 and $13,892, respectively) 16,534 16,363 TOTAL $ 2,996,166 $ 2,434,125 ============ ============ LIABILITIES AND STOCKHOLDERS' EQUITY CURRENT LIABILITIES: Accounts payable and accrued expenses $ 23,105 $ 1,781 Note payable to related party - - Total current liabilities 23,105 1,781 CONVERTIBLE NOTES PAYABLE - LONG TERM - - Total liabilities 23,105 1,781 STOCKHOLDERS' EQUITY: Convertible preferred stock, $.001 par value, 5,000,000 shares authorized; 4,000,000 shares issued and outstanding, no liquidation value 4,000 4,000 Common stock, $.01 par value, 500,000,000 shares authorized; 31,611,441 and 28,277,912 shares issued and outstanding, respectively 316,115 282,780 Additional paid-in capital 3,265,009 2,590,344 Stock subscription receivable (2,958) (2,958) Stock purchase warrants 147,834 147,834 Deficit (756,939) (589,656) Total stockholders' equity 2,973,061 2,432,344 TOTAL $ 2,996,166 $ 2,434,125 ============ ============ NET ASSET VALUE PER SHARE $ 0.09 $ 0.09 ============ ============ ____________________________________________________________________________________ See notes to condensed financial statements. 4 HydroFlo, Inc. STATEMENTS OF OPERATIONS (unaudited) __________________________________________________________________________________________ Prior to converting to a Business Development Company ("BDC") _____________ For the three For the three months ended months ended September 30, 2004 September 30, 2003 REVENUE $ - $ 68,818 COST OF GOODS SOLD - 16,798 GROSS MARGIN - 52,020 OPERATING EXPENSES: Employee compensation 450 242,129 Management fee 13,800 13,800 Research and development - 470 Rent 4,379 4,728 Marketing 51,995 2,087 General and administrative 84,234 190,736 Total operating expenses 154,858 453,950 OPERATING LOSS - 401,930 OTHER INCOME - Interest income 1,746 278 NET UNREALIZED LOSS ON INVESTMENTS 14,170 - NET LOSS $ (167,282) $ (401,652) ============== ============= NET LOSS PER SHARE - Basic and Diluted $ (0.01) $ (0.03) ============== ============= WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING - Basic and Diluted 30,441,800 15,811,485 ============== ============= __________________________________________________________________________________________ See notes to condensed financial statements. 5 HydroFlo, Inc. STATEMENTS OF CASH FLOWS (unaudited) ____________________________________________________________________________________________________ Prior to converting to a Business Development Company ("BDC") ______________ For the For the three months three months ended September ended September 30, 2004 30, 2003 CASH FLOWS FROM OPERATING ACTIVITIES: Net loss $ (167,282) $ (401,652) Adjustments to reconcile net loss to net cash provided by (used in) operating activities: Depreciation 1,483 5,562 Amortization of patent costs - 140 Stock based Compensation - 203,887 Loss on impairment of patent costs - 5,949 (Increase) decrease in accounts receivable - (53,735) (Increase) decrease in inventory, net - (27,682) Decrease (increase) in prepaid expenses - 74,483 Increase in accounts payable and accrued expenses 21,324 64,583 Increase in deferred revenue - 417 NET CASH (USED IN) OPERATING ACTIVITIES (144,475) (128,048) CASH FLOWS FROM INVESTING ACTIVITIES: Investment in controlled companies (129,000) - Purchases of property and equipment (1,655) (2,686) NET CASH (USED IN) INVESTING ACTIVITIES (130,655) (2,686) CASH FLOWS FROM FINANCING ACTIVITIES- Issuances of common stock, net of transaction expenses 228,000 - NET (DECREASE) INCREASE IN CASH (47,130) (130,734) CASH AT BEGINNING OF PERIOD 406,762 131,373 CASH AT END OF PERIOD $ 359,632 $ 639 ============ =========== SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: Income taxes paid $ - $ - ============ =========== Interest paid $ - $ - ============ =========== SUPPLEMENTAL DISCLOSURE OF CASH NON-CASH INANCING ACTIVITES: Common stock issued for services rendered $ - $ 68,000 ============ =========== Commons stock issued to acquire investment $ 480,000 $ - ============ =========== ____________________________________________________________________________________________________ See notes to condensed financial statements. 6 HydroFlo, Inc. NOTES TO FINANCIAL STATEMENTS (Unaudited) ________________________________________________________________________________ Note A - Summary of Significant Accounting Policies Nature of Operations and Background HydroFlo, Inc. (the "Company") was incorporated in North Carolina on December 8, 1999, to design and distribute aeration and oxygen mixing equipment specifically designed for municipalities and industry requiring improved dissolved oxygen in water. From inception to June 30, 2002, the Company focused primarily on developing and patenting this new technology for the sewage treatment industry. Beginning July 1, 2002, the Company emerged from the development stage and focused on marketing and selling their technology to this industry. Effective March 4, 2004, the Company became a diversified internally managed, closed-end investment company that elected to be treated as a business development company ("BDC") under the Investment Company Act of 1940, as amended. As a BDC, the Company intends to provide long-term debt and equity investment capital to support the expansion of companies in a variety of industries. These investments are expected to generally be illiquid securities negotiated through private transactions. In connection with the Company's conversion to a BDC, the Company formed Hydroflo Water Treatment, Inc., and simultaneously transferred substantially all of its operating assets and liabilities (exclusive of cash and certain property and equipment) to such entity. HydroFlo Water Treatment, Inc. is an international provider of wastewater pre-treatment solutions, treating wastewater for industrial and municipal customers. HydroFlo designs, builds, and installs water and wastewater treatment systems and provides a full range of related services to companies and municipalities to treat their wastewater. Basis of Presentation In accordance with SEC rules and regulations for BDCs, the Company does not consolidate or use the equity method to account for its controlling investment in HydroFlo Water Treatment, Inc. Rather, the Company's investment in such entity is reported at fair value, and the fluctuation in such fair value since the date of the conversion to a BDC has been reflected as an unrealized loss on investment in the accompanying unaudited statement of operations. Our accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and the instructions to Form 10-Q and Regulation S-X of the Securities and Exchange Commission (the "SEC"). Accordingly, these unaudited condensed financial statements do not include all of the footnotes required by accounting principles generally accepted in the United States of America. In our opinion, all adjustments (consisting of normal and recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the three months ended September 30, 2004 are not necessarily indicative of the results that may be expected for the year ended June 30, 2005. The accompanying condensed financial statements and the notes thereto should be read in conjunction with our audited financial statements as of and for the year ended June 30, 2004 contained in our Form 10-K. Although the nature of the Company's operations and its reported financial position, results of operations and cash flows are dissimilar for the periods prior and subsequent to becoming a BDC, its unaudited financial position as of 7 September 30, 2004 and June 30, 2004, and its unaudited operating results and cash flows for the three months ended September 30, 2004 and 2003 are presented in the accompanying financial statements pursuant to Regulation S-X. Going Concern The Company has suffered net losses and negative cash flows from operations since its inception. These losses have been funded through the sale of common stock, primarily to related parties. Until such time that the Company can generate sustained profitable operations (for which no assurance can be given), the Company will require additional funding to implement its business plan. Management believes it will be able to raise any additional capital it may need; however there can be no assurance that the Company will be successful in any such efforts, or that any such financing will be on terms favorable, or acceptable, to the Company. The accompanying unaudited financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should the Company be unable to continue as a going concern. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statement and the reported amounts of revenues and expenses during the reporting period. Estimates that are critical to the accompanying financial statements arise from the determination of the fair value of the Company's investments. Because such determination involves subjective judgment, it is at least reasonably possible that the Company's estimates could change in the near term with respect to this matter. Earnings (Loss) Per Share In accordance with the provisions of SFAS No. 128, "Earnings Per Share," basic earnings (loss) per share is computed by dividing net income (loss) by the number of weighted-average common shares outstanding during the year. Diluted earnings per share is computed by dividing net income (loss) by the number of weighted average common shares outstanding adjusted to include the number of additional common shares that would have been outstanding if the dilutive potential common shares resulting from common stock equivalents granted had been issued. The effect of options and warrants outstanding were not included in the computation of diluted earnings per share because the effect on net loss per share would have been antidilutive. Accordingly, basic and diluted net loss per share are identical for each of the periods in the accompanying statements of operations. Stock-Based Compensation The Company has adopted Statement of Financial Accounting Standards No. 148 "Accounting for Stock-Based Compensation - Transition and Disclosure". This statement amends FASB statement No. 123, "Accounting for Stock Based Compensation". It provides alternative methods of transition for an entity that voluntarily changes to the fair value based method of accounting for employee stock based compensation. It also amends the disclosure provision of FASB statement No. 123 to require prominent disclosure about the effects on reported net income of an entity's accounting policy decisions with respect to stock-based employee compensation. As permitted by SFAS No. 123 and amended by SFAS No. 148, we continue to apply the intrinsic value method under Accounting Principles Board ("APB") Opinion No. 25, "Accounting for Stock Issued to Employees," to account for our stock-based employee compensation arrangements. Had our compensation expense for stock-based compensation plans been determined based upon fair values at the grant dates for awards under this plan in accordance with SFAS No. 123, "Accounting for Stock-Based Compensation," our net loss and pro forma net loss per share amounts would not have been materially different. 8 Valuation of Investments and Revenue Recognition (After conversion to a BDC) As required by the SEC's Accounting Series Release ("ASR") 118, the investment committee of the Company is required to assign a fair value to all investments. To comply with Section 2(a)(41) of the Investment Company Act of 1940 (the "Act") and Rule 2a-4 under the Act, it is incumbent upon the board of directors to satisfy themselves that all appropriate factors relevant to the value of securities for which market quotations are not readily available have been considered and to determine the method of arriving at the fair value of each such security. To the extent considered necessary, the board may appoint persons to assist them in the determination of such value, and to make the actual calculations pursuant to the board's direction. The board must also, consistent with this responsibility, continuously review the appropriateness of the methods used in valuing each issue of security in the Company's portfolio. The directors must recognize their responsibilities in this matter and whenever technical assistance is requested from individuals who are not directors, the findings of such intervals must be carefully reviewed by the directors in order to satisfy themselves that the resulting valuations are fair. Where there is not a readily available source for determining the market value of an investment, either because the investment is not publicly traded, or is thinly traded, and in absence of a recent appraisal, the value of the investment shall be based on the following criteria: - - Total amount of the Company's actual investment ("AI"). This amount shall include all loans, purchase price of securities, and fair value of securities given at the time of exchange. - - Total revenues for the preceding twelve months ("R"). - - Earnings before interest, taxes and depreciation ("EBITD") - - Estimate of likely sale price of investment ("ESP") - - Net assets of investment ("NA") - - Likelihood of investment generating positive returns (going concern). The estimated value of each such investment shall be determined as follows: - - Where no or limited revenues or earnings are present, then the value shall be the greater of the investment's a) net assets, b) estimated sales price, or c) total amount of actual investment. - - Where revenues and/or earnings are present, then the value shall be the greater of one time (1x) revenues or three times (3x) earnings, plus the greater of the net assets of the investment or the total amount of the actual investment. - - Under both scenarios, the value of the investment shall be adjusted down if there is a reasonable expectation that the Company will not be able to recoup its investment or if there is reasonable doubt about the investee's ability to continue as a going concern. Note B - Acquisition of Portfolio Company On August 4, 2004 the Company acquired Arsenic Removal Technologies, Inc, a company holding the arsenic removal technology rights developed by the University of Wyoming. This portfolio company was purchased using 2,823,529 shares of restricted common stock of the Company, valued at approximately 9 $480,000 based on the fair market value of the shares issued on that date. We hold 100% of the stock in this company and plan to develop and market the technology throughout the world. After purchase, the company was re-incorporated in North Carolina with a change of name to Metals & Arsenic Removal Technology, Inc. Note C - Stockholders' Equity During the three months ended September 30, 2004 we sold 510,000 shares of our common stock at prices ranging from $0.05 to $0.50/share. These transactions generated gross proceeds to the Company of $228,000. 10 Item 2. MANAGEMENT'S DISCUSSION AND PLAN OF OPERATIONS MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION. The information contained in this section should be read in conjunction with the Selected Financial Data and our Financial Statements and notes thereto appearing elsewhere in this 10Q. The 10Q, including the Management's Discussion and Analysis of Financial Condition and Results of Operations, contains forward-looking statements that involve substantial risks and uncertainties. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about our industry, our beliefs, and our assumptions. Words such as "anticipates", "expects", "intends", "plans", "believes", "seeks", and "estimates" and variations of these words and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements including without limitation (1) any future economic downturn could impair our ability to increase our non-performing assets, (2) a contraction of available credit and/or an inability to access the equity markets could impair our investment activities, (3) the risks associated with the possible disruption in the Company's operations due to terrorism and (4) the risks, uncertainties and other factors we identify from time to time in our filings with the Securities and Exchange Commission, including our Form 10-Ks, Form 10-Qs and Form 8-Ks. Although we believe that the assumptions on which these forward-looking statements are based are reasonable, any of those assumptions could prove to be inaccurate, and as a result, the forward-looking statements based on those assumptions also could be incorrect. In light of these and other uncertainties, the inclusion of a projection or forward-looking statement in this Annual Report should not be regarded as a representation by us that our plans and objectives will be achieved. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this Annual Report. OVERVIEW The following discussion should be read in conjunction with the unaudited condensed financial statements as of and for the three months ended September 30, 2004 included with this Form 10Q. Effective March 4, 2004, we converted to a Business Development Company under the Investment Company Act of 1940. Upon completion of this conversion, we became an internally managed, diversified, closed-end investment company. Prior to the conversion we were an operating company. Those operations were transferred to HydroFlo Water Treatment, Inc., a wholly owned investment of ours. HydroFlo Water Treatment, Inc., is an international provider of wastewater pre-treatment solutions, treating wastewater for industrial and municipal customers. HydroFlo designs, builds, and installs water and wastewater treatment systems and provides a full range of related services to companies and municipalities to treat their wastewater. Because of our conversion to a Business Development Company ("BDC") the results of operations for the three months ended September 30, 2003 (pre conversion) are not comparable to the three months ended September 30, 2004 (post conversion). The principal differences between these two reporting periods are: (1) we no longer include the operations of our operating ("portfolio") companies in our financial statements, and (2) we now value our ownership of the portfolio companies at fair value. 11 THREE MONTHS ENDED SEPTEMBER 30, 2004 (POST-CONVERSION TO A BUSINESS DEVELOPMENT CORPORATION) PORTFOLIO COMPOSITION Our primary business is investing in businesses with equity-based investments. The total portfolio value of investments in non-publicly traded securities was approximately $2,620,000 million at fair value at September 30, 2004. OPERATIONS We generated no income during the three months ended September 30, 2004. We incurred approximately $155,000 in expenses during this period. These expenses represented management fees to our CEO, rent and other cash expenses associated with operating the BDC and seeking additional investments. NET UNREALIZED LOSS ON INVESTMENTS During the three months ended September 30, 2004, we recorded approximately $14,000 in unrealized losses on our portfolio company investments. This loss represents the difference between the amount our Board of Directors determined was the fair value of the portfolio companies and the amounts we have invested in those companies, including prior adjustments for unrealized gain or loss. NET LOSS As a result of the foregoing, we incurred a net loss of approximately $167,000 for the three months ended September 30, 2004. THREE MONTHS ENDED SEPTEMBER 30, 2003 (PRIOR TO CONVERTING TO A BUSINESS DEVELOPMENT CORPORATION) OPERATING INCOME Our aggregate sales were approximately $69,000 for the three months ended September 30, 2003. OPERATING EXPENSES Employee compensation expenses were approximately $242,000 for the three months ended September 30, 2003. Management fees (related-party) expenses were $13,800 for the three months ended September 30, 2003. Research and development expenses were $470 for the three months ended September 30, 2003. Other General and Administrative expenses were approximately $191,000 for the three months ended September 30, 2003. NET LOSS As a result of the foregoing, we incurred a loss of approximately $402,000 for the three months ended September 30, 2003. FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES At September 30, 2004 we had approximately $360,000 in cash and cash equivalents. Our objective is to maintain a low cash balance, while keeping sufficient cash on hand to cover current funding requirements and operations. For the next eight months, we expect our cash on hand and cash generated from operations to be adequate to meet our cash needs, including additional advances to the companies we invest in. Management's plans regarding continued operations include the possibility of raising additional equity capital via the sale of 12 stock which can now be accomplished due to the filing as a Business Development Company. Aggressive sales efforts in our portfolio companies will likely increase sales of product by the portfolio companies in the coming year and may result in less funding we need to provide to them or may even result in a cash return on our investment. PRIVATE PORTFOLIO COMPANY INVESTMENTS The following is a list of the private companies in which we had an investment and the cost and fair value of such securities at September 30, 2004: Name of Company Nature of its Principal Business Approximate Cost Fair Value HydroFlo Water Treatment, Inc. Waste water treatment solutions $2,139,000 $2,100,000 Arsenic Removal Technologies, Inc Arsenic removal technology $492,000 $520,000 ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK Our business activities contain elements of risk. We consider the principal types of risk to be portfolio valuations. We consider the management of risk essential to conducting our businesses. Accordingly, our risk management systems and procedures are designed to identify and analyze our risks, to set appropriate policies and limits and to continually monitor these risks and limits by means of reliable administrative and information systems and other policies and programs. As a business development company, we invest in illiquid securities including equity securities of primarily private companies. Our investments are generally subject to restrictions on resale and generally have no established trading market. We value substantially all of our investments at fair value as determined in good faith by the board of directors in accordance with our valuation policy. There is no single standard for determining fair value in good faith. As a result, determining fair value requires that judgment be applied to the specific facts and circumstances of each portfolio investment while employing a consistently applied valuation process for the types of investments we make. We determine fair value to be the amount for which an investment could be exchanged in an orderly disposition over a reasonable period of time between willing parties other than in a forced or liquidation sale. Our valuation policy considers the fact that no ready market exists for substantially all of the securities in which we invest. Our valuation policy is intended to provide a consistent basis for determining the fair value of the portfolio. We will record unrealized depreciation on investments when we believe that an investment has become impaired, including where collection of a loan or realization of an equity security is doubtful, or when the enterprise value of the company does not currently support the cost of our debt or equity investments. Conversely, we will record unrealized appreciation if we believe that the underlying portfolio company has appreciated in value and, therefore, our equity security has also appreciated in value. The value of investments in public securities is determined using quoted market prices discounted for restrictions on resale. Without a readily ascertainable market value and because of the inherent uncertainty of valuation, the fair value of our investments determined in good faith by the board of directors may differ significantly from the values that would have been used had a ready market existed for the investments, and the differences could be material. In addition, the illiquidity of our investments may adversely affect our ability to dispose of debt and equity securities at times when it may be otherwise advantageous for us to liquidate such investments. In addition, if we were forced to immediately liquidate some or all of the investments in the portfolio, the proceeds of such liquidation would be significantly less than the current value of such investments. Impact of Inflation We do not believe that our business is materially affected by inflation, other than the impact that inflation may have on the securities markets, the valuations of business enterprises and the relationship of such valuations to underlying earnings, all of which will influence the value of our investments. 13 ITEM 4. CONTROLS AND PROCEDURES Disclosure Controls and Procedures The Corporation maintains disclosure controls and procedures designed to ensure that information required to be disclosed in reports filed under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the specified time periods. As of the end of the period covered by this report, the Corporation's Chief Executive Officer and Chief Financial Officer evaluated the effectiveness of the Corporation's disclosure controls and procedures. Based on the evaluation, which disclosed no significant deficiencies or material weaknesses, the Corporation's Chief Executive Officer and Chief Financial Officer concluded that the Corporation's disclosure controls and procedures are effective as of the end of the period covered by this report. Changes in Internal Controls There have been no changes in the Corporation's internal control over financial reporting that occurred during the Corporation's most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Corporation's internal control over financial reporting. However, we intend to continue to refine our internal controls on an ongoing basis with a view towards continuous improvements. Grant Thornton LLP ("GT"), our previous independent accountants, had reported to our Board of Directors certain matters involving internal controls that GT considered to be material weaknesses under standards established by the American Institute of Certified Public Accountants. The identified material weaknesses related to a lack of segregation of duties within our accounting and financial management functions and inadequate dedication of resources to the financial review and analysis functions. Due to the size of our organization, the early stage of our operations and significant financial constraints, the Corporation has not been able to employ the necessary resources for proper internal financial review and analysis. Given the material weaknesses identified above, management devoted additional resources to resolving questions that arose during the quarterly reporting cycle. Significant adjustments were necessary to convert management's internal financial records to the final reported amounts in the Form 10Q. As a result, management is confident that its financial statements fairly present, in all material respects, the financial condition and results of operations of the Company. The material weaknesses have been discussed in detail among our Board of Directors and GT. We have assigned high priority to the correction of these material weaknesses, and we are committed to addressing and resolving them fully. As the Corporation continues its growth and strives to achieve financial stability, management intends to devote additional resources to further develop its financial accounting, analysis and reporting functions. 14 PART II - OTHER INFORMATION ITEM 1. LEGAL PROCEEDINGS Not Applicable. ITEM 2 CHANGES IN SECURITIES AND USE OF PROCEEDS On August 4, 2004 the Company acquired Arsenic Removal Technologies, Inc, a company holding the arsenic removal technology rights developed by the University of Wyoming. This portfolio company was purchased using 2,823,529 shares of restricted common stock of the Company, valued at approximately $480,000 based on the fair market value of the shares issued on that date. We hold 100% of the stock in this company and plan to develop and market the technology throughout the world. After purchase, the company was re-incorporated in North Carolina with a change of name to Metals & Arsenic Removal Technology, Inc. During the three months ended September 30, 2004 we sold 510,000 shares of our common stock at prices ranging from $0.05 to $0.50/share. These transactions generated gross proceeds to the Company of $228,000. ITEM 3. DEFAULTS UPON SENIOR SECURITIES Not Applicable. ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS Not Applicable. ITEM 5. OTHER INFORMATION Not Applicable. ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K (a) Exhibits The following exhibits are filed as part of this Form 10-Q. 31.1 Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer 32.1 Section 1350 Certification (b) Reports on Form 8-K. None SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on November 15, 2004. HydroFlo, Inc. /s/ DENNIS L. MAST Dennis L. Mast Chief Executive Officer Chief Financial Officer 15